Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor–Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
出版年份 2022 全文链接
标题
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor–Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2022-03-04
DOI
10.1200/jco.21.01806
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
- (2020) Esther Lutgens et al. Journal for ImmunoTherapy of Cancer
- Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
- (2020) Lars Michel et al. ESC Heart Failure
- Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
- (2020) T.K. Choueiri et al. ANNALS OF ONCOLOGY
- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
- (2020) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events
- (2020) Viktor Grünwald et al. BRITISH JOURNAL OF CANCER
- Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
- (2020) Radek Pudil et al. EUROPEAN JOURNAL OF HEART FAILURE
- Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience
- (2019) Katherine Lee Chuy et al. ONCOLOGIST
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
- (2019) Brian I Rini et al. LANCET
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies
- (2019) Christina W. Guo et al. EUROPEAN JOURNAL OF CANCER
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
- (2018) Rhian M. Touyz et al. Journal of the American Society of Hypertension
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- The Role of Biomarkers in Detection of Cardio-toxicity
- (2017) Kevin S. Shah et al. Current Oncology Reports
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
- (2016) Anne-Sophie Bargnoux et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Cardiovascular Toxic Effects of Targeted Cancer Therapies
- (2016) Javid J. Moslehi NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
- (2015) N. B. Haas et al. CLINICAL CANCER RESEARCH
- Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction
- (2014) M. Rubini Gimenez et al. EUROPEAN HEART JOURNAL
- Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
- (2013) Steven M. Bair et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC)
- (2013) Ruth F Dubin et al. BMC Nephrology
- Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
- (2011) F. S. Apple et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started